Abstract
Abciximab was administered intravenously to three patients to treat thrombus associated with atherosclerotic stenosis of a supra-aortic artery. In two cases, the thrombi had been identified on a previous angiography more than a week before treatment. Successful thrombolysis was achieved with abciximab in all three cases. In this small series, abciximab had a thrombolytic effect on established thrombi that were refractory to previous antithrombotic treatment attempts.
MeSH terms
-
Abciximab
-
Antibodies, Monoclonal / administration & dosage*
-
Anticoagulants / administration & dosage*
-
Cerebral Angiography
-
Female
-
Humans
-
Immunoglobulin Fab Fragments / administration & dosage*
-
Injections, Intravenous
-
Intracranial Arteriosclerosis / diagnosis
-
Intracranial Arteriosclerosis / therapy
-
Intracranial Thrombosis / diagnosis
-
Intracranial Thrombosis / therapy*
-
Male
-
Middle Aged
-
Thrombolytic Therapy*
Substances
-
Antibodies, Monoclonal
-
Anticoagulants
-
Immunoglobulin Fab Fragments
-
Abciximab